OBJECTIVE: To evaluate the clinical performance of the lesion-to-cerebellum uptake ratio (LCR), a semiquantitative index for differentiating malignant from benign lung nodules with [F]fluorodeoxyglucose positron emission tomography (F-FDG PET). METHODS: Thirty-six patients (16 females, 20 males; median age, 73 years; range, 41-87 years) with 42 known or suspected malignant lung nodules underwent whole-body PET imaging after an intravenous injection of a mean dose of 543+/-69 MBq (14.7+/-1.9 mCi) of F-FDG. The standardized uptake value (SUV) and the LCR were calculated for each nodule and receiver operating characteristic (ROC) curves were analysed using the ROCKIT 0.9B software package. RESULTS: Surgical pathology and follow-up with serial computed tomography scans for at least 24 months revealed 18 malignant lung lesions and 24 benign lesions less than 3.0 cm in size. The mean LCR was 0.70+/-0.40 for malignant nodules and 0.23+/-0.12 for benign nodules (P<0.001, two-tailed test). The area under the estimated ROC curve was 0.8660 for SUV data and 0.9197 for LCR data (P=0.2408, two-tailed test). CONCLUSIONS: The LCR method appears to be a valuable semiquantitative index for the evaluation of malignancy in pulmonary nodules with F-FDG PET, which is simple to perform clinically and does not require accurate measurements of body weight or the residual activity in the syringe utilized for F-FDG injection.
OBJECTIVE: To evaluate the clinical performance of the lesion-to-cerebellum uptake ratio (LCR), a semiquantitative index for differentiating malignant from benign lung nodules with [F]fluorodeoxyglucose positron emission tomography (F-FDG PET). METHODS: Thirty-six patients (16 females, 20 males; median age, 73 years; range, 41-87 years) with 42 known or suspected malignant lung nodules underwent whole-body PET imaging after an intravenous injection of a mean dose of 543+/-69 MBq (14.7+/-1.9 mCi) of F-FDG. The standardized uptake value (SUV) and the LCR were calculated for each nodule and receiver operating characteristic (ROC) curves were analysed using the ROCKIT 0.9B software package. RESULTS: Surgical pathology and follow-up with serial computed tomography scans for at least 24 months revealed 18 malignant lung lesions and 24 benign lesions less than 3.0 cm in size. The mean LCR was 0.70+/-0.40 for malignant nodules and 0.23+/-0.12 for benign nodules (P<0.001, two-tailed test). The area under the estimated ROC curve was 0.8660 for SUV data and 0.9197 for LCR data (P=0.2408, two-tailed test). CONCLUSIONS: The LCR method appears to be a valuable semiquantitative index for the evaluation of malignancy in pulmonary nodules with F-FDG PET, which is simple to perform clinically and does not require accurate measurements of body weight or the residual activity in the syringe utilized for F-FDG injection.
Authors: Xiaofan Xiong; Timothy J Linhardt; Weiren Liu; Brian J Smith; Wenqing Sun; Christian Bauer; John J Sunderland; Michael M Graham; John M Buatti; Reinhard R Beichel Journal: Med Phys Date: 2020-01-06 Impact factor: 4.071
Authors: Brenda F Kurland; Elizabeth R Gerstner; James M Mountz; Lawrence H Schwartz; Christopher W Ryan; Michael M Graham; John M Buatti; Fiona M Fennessy; Edward A Eikman; Virendra Kumar; Kenneth M Forster; Richard L Wahl; Frank S Lieberman Journal: Magn Reson Imaging Date: 2012-08-13 Impact factor: 2.546
Authors: Christian Bauer; Shanhui Sun; Wenqing Sun; Justin Otis; Audrey Wallace; Brian J Smith; John J Sunderland; Michael M Graham; Milan Sonka; John M Buatti; Reinhard R Beichel Journal: Med Phys Date: 2012-06 Impact factor: 4.071
Authors: Zuyao Y Shan; Andrew J Leiker; Arzu Onar-Thomas; Yimei Li; Tianshu Feng; Wilburn E Reddick; David C Reutens; Barry L Shulkin Journal: Hum Brain Mapp Date: 2013-07-29 Impact factor: 5.038
Authors: Irene Gramaglia; Joyce Velez; Yu-Sun Chang; Wilson Caparros-Wanderley; Valery Combes; Georges Grau; Monique F Stins; Henri C van der Heyde Journal: PLoS One Date: 2019-03-08 Impact factor: 3.240